These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 33478491

  • 1. Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study.
    Magnussen H, Lucas S, Lapperre T, Quint JK, Dandurand RJ, Roche N, Papi A, Price D, Miravitlles M, Respiratory Effectiveness Group (REG).
    Respir Res; 2021 Jan 21; 22(1):25. PubMed ID: 33478491
    [Abstract] [Full Text] [Related]

  • 2. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA, Franssen FME, van Kraaij S, Braeken DCW, Wouters EFM, Maitland-van der Zee AH, Driessen JHM, de Vries F.
    COPD; 2019 Apr 21; 16(2):152-159. PubMed ID: 31117850
    [Abstract] [Full Text] [Related]

  • 3. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
    Watz H, Tetzlaff K, Wouters EF, Kirsten A, Magnussen H, Rodriguez-Roisin R, Vogelmeier C, Fabbri LM, Chanez P, Dahl R, Disse B, Finnigan H, Calverley PM.
    Lancet Respir Med; 2016 May 21; 4(5):390-8. PubMed ID: 27066739
    [Abstract] [Full Text] [Related]

  • 4. Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.
    Suissa S, Dell'Aniello S, Ernst P.
    Lancet Respir Med; 2018 Nov 21; 6(11):855-862. PubMed ID: 30343028
    [Abstract] [Full Text] [Related]

  • 5. Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline.
    Ferguson GT, Shaikh A, Tetzlaff K, Mueller A, Magnussen H, Watz H.
    Int J Chron Obstruct Pulmon Dis; 2020 Nov 21; 15():2879-2888. PubMed ID: 33204084
    [Abstract] [Full Text] [Related]

  • 6. Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study.
    Bloom CI, Douglas I, Usmani OS, Quint JK.
    Int J Chron Obstruct Pulmon Dis; 2020 Nov 21; 15():701-710. PubMed ID: 32308379
    [Abstract] [Full Text] [Related]

  • 7. Withdrawal of Inhaled Corticosteroids from Patients with COPD; Effect on Exacerbation Frequency and Lung Function: A Systematic Review.
    Georgiou A, Ramesh R, Schofield P, White P, Harries TH.
    Int J Chron Obstruct Pulmon Dis; 2024 Nov 21; 19():1403-1419. PubMed ID: 38919905
    [Abstract] [Full Text] [Related]

  • 8. "Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD.
    Vogelmeier C, Worth H, Buhl R, Criée CP, Lossi NS, Mailänder C, Kardos P.
    Int J Chron Obstruct Pulmon Dis; 2017 Nov 21; 12():487-494. PubMed ID: 28203072
    [Abstract] [Full Text] [Related]

  • 9. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
    Chalmers JD, Poole C, Webster S, Tebboth A, Dickinson S, Gayle A.
    Respir Res; 2018 Apr 11; 19(1):63. PubMed ID: 29642882
    [Abstract] [Full Text] [Related]

  • 10. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO).
    Rossi A, Guerriero M, Corrado A, OPTIMO/AIPO Study Group.
    Respir Res; 2014 Jul 08; 15(1):77. PubMed ID: 25005873
    [Abstract] [Full Text] [Related]

  • 11. Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts.
    Lee SH, Lee JH, Yoon HI, Park HY, Kim TH, Yoo KH, Oh YM, Jung KS, Lee SD, Lee SW.
    Respir Res; 2019 Mar 28; 20(1):62. PubMed ID: 30922302
    [Abstract] [Full Text] [Related]

  • 12. Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice.
    Kaplan AG.
    Int J Chron Obstruct Pulmon Dis; 2015 Mar 28; 10():2535-48. PubMed ID: 26648711
    [Abstract] [Full Text] [Related]

  • 13. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G, Cotton S, Fielding S, McMeekin N, Barnes PJ, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, Soyza A, Gompertz S, Haughney J, Innes K, Kaniewska J, Lee A, Morice A, Norrie J, Sullivan A, Wilson A, Price D.
    Health Technol Assess; 2019 Jul 28; 23(37):1-146. PubMed ID: 31343402
    [Abstract] [Full Text] [Related]

  • 14. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
    Yang IA, Clarke MS, Sim EH, Fong KM.
    Cochrane Database Syst Rev; 2012 Jul 11; 2012(7):CD002991. PubMed ID: 22786484
    [Abstract] [Full Text] [Related]

  • 15. Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice.
    Suissa S, Dell'Aniello S, Ernst P.
    COPD; 2022 Jul 11; 19(1):133-141. PubMed ID: 35392746
    [Abstract] [Full Text] [Related]

  • 16. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
    Pascoe S, Barnes N, Brusselle G, Compton C, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Hartley B, Lange P, Lettis S, Lipson DA, Lomas DA, Martinez FJ, Papi A, Roche N, van der Valk RJP, Wise R, Singh D.
    Lancet Respir Med; 2019 Sep 11; 7(9):745-756. PubMed ID: 31281061
    [Abstract] [Full Text] [Related]

  • 17. Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety.
    Suissa S, Dell'Aniello S, Ernst P.
    Int J Chron Obstruct Pulmon Dis; 2022 Sep 11; 17():1975-1986. PubMed ID: 36065315
    [Abstract] [Full Text] [Related]

  • 18. Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice.
    Suissa S, Dell'Aniello S, Ernst P.
    Chest; 2020 Apr 11; 157(4):846-855. PubMed ID: 31759966
    [Abstract] [Full Text] [Related]

  • 19. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.
    Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, Rossi A, Hutton C, Ashton VL, Stewart R, Bichel K.
    Int J Chron Obstruct Pulmon Dis; 2014 Apr 11; 9():889-904. PubMed ID: 25210450
    [Abstract] [Full Text] [Related]

  • 20. Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD.
    Cheng SL, Wang HH, Lin CH.
    Int J Chron Obstruct Pulmon Dis; 2017 Apr 11; 12():2231-2238. PubMed ID: 28814851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.